AI assistant
VOLITIONRX LTD — Director's Dealing 2022
Apr 8, 2022
34395_dirs_2022-04-08_c1b45ad0-b4f4-4841-ba07-f81617400a04.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-04-07-05:00
Reporting Person: Butera Salvatore Thomas (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-04-07-05:00 | Stock Option (Right to Buy) | $3.40 | A | 18340 | Acquired | 2031-08-03-05:00 | Common Stock (18340) | Direct |
Footnotes
F1: On August 3, 2021, the reporting person was granted an option to purchase 52,400 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 18,340 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 9,170 shares on each of August 3, 2022 and August 3, 2023, respectively.